Gregory H. Reaman, M.D. is Professor of Pediatrics at George Washington University School of Medicine and Health Sciences in Washington, D.C. and a member of the Division of Hematology-Oncology and Executive Director Emeritus of the Center for Cancer and Blood Disorders at the Children’s National Medical Center, which he directed for more than 17 years.
He is the Inaugural Chair of the Children’s Oncology Group (COG) having served in this capacity from 2000 through 2010. The COG is comprised of over 200 member institutions, dedicated to clinical, translational, and epidemiology research in childhood cancer. Prior to this, he was the Vice Chair for Scientific Affairs and the Associate Chair for New Agent Studies of the Children’s Cancer Group (CCG) for 10 years and directed the CCG Phase I Consortium.
He joined the FDA in 2011 as the Associate Director for Oncology Sciences in the Office of Hematology and Oncology in the Center for Drug Evaluation and Research. Dr. Reaman serves or has served on several editorial boards; he served as an Associate Editor of Cancer and Leukemia and Lymphoma. He served on the Board of Directors of the American Cancer Society and chaired its Task Force on Children and Cancer and has served on the Board of Directors of the American Society of Clinical Oncology (ASCO) and has served on numerous ASCO committees. He was elected to the Board of SIOP as treasurer in 2011.
His research interests are in the biology and treatment of childhood acute leukemia and new drug development for pediatric cancers. He is the author of more than 350 peer – reviewed manuscripts and 20 book chapters and 3 text books.